| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 08/16/2006 | CN1817351A Production of variolaria amra medicinal extract and its medicinal preparation |
| 08/16/2006 | CN1817344A Technology for treating twist disease, hypotension and hypertension |
| 08/16/2006 | CN1269963C Cardiac atrium peptide gene transfecting cell microcapsule |
| 08/16/2006 | CN1269942C Hops extracts, method for prodn. and use |
| 08/16/2006 | CN1269940C Method for extracting lipid from marine and aquatic animal tissues |
| 08/16/2006 | CN1269835C Method for preparing low-polarity ginseng saponin and its aglycone by catalytic pyrolysis |
| 08/16/2006 | CN1269823C 3,7-diazabicyclo [3.3.1] for mulations as anti arhythmiccompounds |
| 08/16/2006 | CN1269822C Inhibitors of cruzipain and other cysteine proteases |
| 08/16/2006 | CN1269820C Novel pyrrole derivatives as pharmaceutical agents |
| 08/16/2006 | CN1269814C Process and intermediates for pyridazinone antidiabetic agents |
| 08/16/2006 | CN1269813C Imidazolo-5-yl-2-anilino-pyrimidines as agents for inhibition of cell proliferation |
| 08/16/2006 | CN1269804C Metalloproteinase inhibitors |
| 08/16/2006 | CN1269801C Amino acid derivatives and drug containing the same as the active ingredient |
| 08/16/2006 | CN1269788C Bicyclic aromatic compound and its application in human medicines or animal medicines and cosmetics teconology |
| 08/16/2006 | CN1269529C Medicinal composition contaniing angiotensin invertase inhibitor and vitamin B |
| 08/16/2006 | CN1269527C Compound alliin powder injection |
| 08/16/2006 | CN1269515C A pharmaceutical composition for treating hypertension, externally applied paste and preparation method thereof |
| 08/15/2006 | USRE39239 Methods for treating early morning pathologies |
| 08/15/2006 | US7091372 Process for the preparation of 1,3-substituted indenes and aryl-fused azapolycyclic compounds |
| 08/15/2006 | US7091353 Isoindole-imide compounds, compositions, and uses thereof |
| 08/15/2006 | US7091352 Antiinflammatory agents; analgesics; antiarthritic agents |
| 08/15/2006 | US7091343 Compositions useful as inhibitors of protein kinases |
| 08/15/2006 | US7091323 Human TIMP-1 antibodies |
| 08/15/2006 | US7091310 Chemokine analogs for the treatment of human disease |
| 08/15/2006 | US7091245 Peroxisome proliferator activator; antidiabetic agents; insulin resistance; |
| 08/15/2006 | US7091242 Beta-amino acid derivatives as integrin receptor antagonists |
| 08/15/2006 | US7091237 Furan and thiophene derivatives that activate human peroxisome proliferator activated receptors |
| 08/15/2006 | US7091232 4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cycloalkylmethyl) imidazol-2-ones and 4-(substituted cycloalkenylmethyl) imidazol-2-ones and related compounds |
| 08/15/2006 | US7091230 2-aryloxy-2-arylalkanoic acids for diabetes and lipid disorders |
| 08/15/2006 | US7091227 Serine/threonine and tyrosine kinases inhibitors |
| 08/15/2006 | US7091225 Substituted oxazoles and thiazoles as hPPAR alpha agonists |
| 08/15/2006 | US7091224 Anthranilic acid amides and their use as VEGF receptor tyrosine kinase inhibitors |
| 08/15/2006 | US7091223 Autoimmune diseases; anticancer agents |
| 08/15/2006 | US7091220 Substituted indole Mannich bases |
| 08/15/2006 | US7091216 antagonists of the Cannabinoid-1 (CB1) receptor; treating obesity |
| 08/15/2006 | US7091215 Corticotropin-Releasing Factor (CRF) receptor antagonist |
| 08/15/2006 | US7091213 Phosphorus-containing compounds and uses thereof |
| 08/15/2006 | US7091210 Substituted 2-aminoacetamides and the use thereof |
| 08/15/2006 | US7091206 Process for producing pyrimidine derivative and intermediate thereof |
| 08/15/2006 | US7091204 Sulfonamides |
| 08/15/2006 | US7091203 Imidazo[1,3,5]triazinones and their use |
| 08/15/2006 | US7091201 Arylalkane-sulfonamides having endothelin-antagonist activity |
| 08/15/2006 | US7091187 Using steroid; autoimmune disease |
| 08/15/2006 | US7091175 activating neovascularization by administering heptapeptides having replacements in the amino acid sequence; antiischemic agents; regeneration and maintenance of artificial bones |
| 08/15/2006 | US7091022 Mitogen activated kinase |
| 08/15/2006 | US7091006 Isolated nucleic acid of given sequence; use in identifying metabolic and neurological disorders |
| 08/15/2006 | US7090871 Composition containing pyrrolizidine-alkaloid-free petasites |
| 08/15/2006 | US7090835 Modified colony stimulating factor for treatment of hematopoietic disorder |
| 08/15/2006 | CA2287267C Improved methods for processing activated protein c |
| 08/15/2006 | CA2256309C Amidino protease inhibitors |
| 08/15/2006 | CA2238871C Method of using beta-interferons to treat restenosis |
| 08/15/2006 | CA2215476C Arginine analogues having nitric oxide synthase inhibitor activity |
| 08/15/2006 | CA2161783C Ampa antagonists and a method of treatment therewith |
| 08/10/2006 | WO2006084015A2 Raf inhibitor compounds and methods |
| 08/10/2006 | WO2006083924A1 1-acylamino-2-hydroxy-3-amino-w-arylalkanes as renin inhibitors |
| 08/10/2006 | WO2006083687A1 Crystal salt of xanthine oxidase inhibitors |
| 08/10/2006 | WO2006083214A1 Pharmaceutical composition comprising a p2x7 receptor antagonist and a hmg-coa reductase inhibitor |
| 08/10/2006 | WO2006082975A1 Optically active tetrahydronaphthalene derivative |
| 08/10/2006 | WO2006082974A1 Remedy for ischemic disease |
| 08/10/2006 | WO2006082952A1 Amide compound |
| 08/10/2006 | WO2006082771A1 Preventive or therapeutic agent for stroke or sequelae of stroke comprising as main component 1-aminocyclopropanecarboxylic acid or the like |
| 08/10/2006 | WO2006082743A1 Therapeutic agent |
| 08/10/2006 | WO2006082412A2 Multimers of pyrimidinone derivatives and their use as human neutrophil elastase inhibitors |
| 08/10/2006 | WO2006082409A2 Tricyclic cytoprotective compounds |
| 08/10/2006 | WO2006081739A1 A composition for treating or preventing hyperlipemia, hypertension and hepatic adipose infiltration |
| 08/10/2006 | WO2006055216A3 Vulnerable plaque treatment |
| 08/10/2006 | WO2006044602A3 Diphenyl substituted alkanes as flap inhiibitors |
| 08/10/2006 | WO2006044415A3 Carboxylic acid peri - substituted bicyclics for occlusive artery disease |
| 08/10/2006 | WO2004050894A3 Heart failure gene determination and therapeutic screening |
| 08/10/2006 | WO2003065999A3 Proliferated cell lines and uses thereof |
| 08/10/2006 | US20060178503 Antibody to an integrin heterodimer and/or a subunit thereof |
| 08/10/2006 | US20060178434 Butenoic acid derivatives processes for the preparation thereof pharmaceutical compositions comprising them and use for the treatment of dyslipidaemia atherosclerosis and diabetes |
| 08/10/2006 | US20060178424 Preventing atrial fibrillation (af) with the use of stain drugs |
| 08/10/2006 | US20060178410 Preparation of N-{2-[4-(3-phenyl-4-methoxyphenyl)aminophenyl]ethyl}-2-hydroxy-2-(3-hydroxymethyl-4-hydroxyphenyl)ethylamine, for example; for the treatment of pulmonary diseases such as asthma and chronic obstructive pulmonary disease |
| 08/10/2006 | US20060178409 Anthranilic acid amides and their use as VEGF receptor tyrosine kinase inhibitors |
| 08/10/2006 | US20060178401 Aminophenoxyacetamide derivatives and pharmaceutical composition containing thereof |
| 08/10/2006 | US20060178375 2-(1-Cyclopentylpiperidin-4-yloxy)-5-(4-cyanophenyl)pyrimidine, for example; exhibits histamine receptor H3 antagonist or inverse agonist activity and is useful for the treatment and/or prevention of obesity, diabetes, hormonal secretion abnormality, sleep disorders |
| 08/10/2006 | US20060178372 Therapeutic quinoline compounds |
| 08/10/2006 | US20060178365 Optionally oxidized 6-(2-(5-methylthio-2-pyrimidinyloxy)ethoxy)-2-phenylpyrimidin-4-yl-substituted sulfamides |
| 08/10/2006 | US20060178359 Tricyclic compound, process for producing the same, and use |
| 08/10/2006 | US20060178356 Treating oxidative stress-related conditions typically responsive to cellular enzyme modulation with a substituted phenolic compound having unsaturated groups, e.g. 1-((3-methyl-5-oxo-2-pyrazolin-1-yl), 4-(3-methoxy-4-hydroxy-phenyl)-vinyl-)benzene; skin disorders; antiischemic and cardiotonic agents |
| 08/10/2006 | US20060178317 Methods of increasing endogenous erythropoietin (EPO) |
| 08/10/2006 | US20060178316 Methods of increasing endogenous erythropoietin (EPO) |
| 08/10/2006 | US20060177528 Formulation Of A Mixture Of Free-B-Ring Flavonoids And Flavans As A Therapeutic Agent |
| 08/10/2006 | US20060177443 Integrin antagonists |
| 08/10/2006 | US20060177433 Treatment of alpha-galactosidase a deficiency |
| 08/10/2006 | US20060177432 Methods and reagents for protease inhibition |
| 08/10/2006 | DE102005005446A1 Bruchfeste Darreichungsformen mit retardierter Freisetzung Unbreakable dosage forms with delayed release |
| 08/10/2006 | CA2596993A1 Optically active tetrahydronaphthalene derivative |
| 08/10/2006 | CA2596973A1 Raf inhibitor compounds and methods |
| 08/10/2006 | CA2596736A1 Tricyclic cytoprotective compounds |
| 08/10/2006 | CA2596444A1 1-acylamino-2-hydroxy-3-amino-w-arylalkanes as renin inhibitors |
| 08/10/2006 | CA2596428A1 Glucuronidated nebivolol_metabolites |
| 08/10/2006 | CA2596426A1 Pharmaceutical composition comprising hydroxylated nebivolol |
| 08/10/2006 | CA2595801A1 Multimers of pyrimidinone derivatives and their use as human neutrophil elastase inhibitors |
| 08/09/2006 | EP1688434A1 Antibody and use of the same |
| 08/09/2006 | EP1688427A1 Perindopril |
| 08/09/2006 | EP1688425A2 Cyclic salen-metal compounds as scavengers for oxygen radicals and useful as antioxidants in the treatment and prevention of diseases |
| 08/09/2006 | EP1688418A2 Chemokine receptor antagonists and methods of use thereof |
| 08/09/2006 | EP1688416A1 Substituted heterocyclic compounds, their process of preparation and pharmaceutical compositions containing them |